Qili Shi

461 total citations
26 papers, 259 citations indexed

About

Qili Shi is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Qili Shi has authored 26 papers receiving a total of 259 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 10 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Qili Shi's work include RNA modifications and cancer (14 papers), RNA Research and Splicing (9 papers) and RNA and protein synthesis mechanisms (5 papers). Qili Shi is often cited by papers focused on RNA modifications and cancer (14 papers), RNA Research and Splicing (9 papers) and RNA and protein synthesis mechanisms (5 papers). Qili Shi collaborates with scholars based in China, South Korea and Canada. Qili Shi's co-authors include Libing Shen, Wenyuan Wang, Xianghuo He, Zhiao Chen, Yizhe Liu, Yanfang Liu, Shenglin Huang, Qun‐Ying Lei, Hongquan Li and Guofang Zhao and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Qili Shi

25 papers receiving 255 citations

Peers

Qili Shi

ONCOL

PRM

IMMUN

Yanxiao Wang China

Rana Yadak Netherlands

Kuniyasu Saigusa Japan

Anna‐Luisa Luger Germany

Quanbin Zhang China

Marian León Spain

María Belén Garcia-Fabiani United States

Mafei Xu China

Tina Fuglsang Daugaard Denmark

Yunfei Liao China

Yanxiao Wang China

Qili Shi

133 ×0.7

74 ×0.8

61 ×1.8

ONCOL

24 ×1.1

PRM

23 ×1.0

IMMUN

Citations per year, relative to Qili Shi Qili Shi (= 1×) peers Yanxiao Wang

Countries citing papers authored by Qili Shi

Since Specialization

Citations

This map shows the geographic impact of Qili Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qili Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qili Shi more than expected).

Fields of papers citing papers by Qili Shi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qili Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qili Shi. The network helps show where Qili Shi may publish in the future.

Co-authorship network of co-authors of Qili Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Qili Shi. A scholar is included among the top collaborators of Qili Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qili Shi. Qili Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shi, Qili, et al.. (2026). Mitochondrial LINC00942 activates complex I and inhibits ferroptosis through interacting with GRSF1 in liver cancer. Science China Life Sciences. 69(2). 438–454.

Li, Hongquan, Yifei He, Zhen Liu, et al.. (2025). CRISPR screening reveals that RNA helicase DDX41 triggers ribosome biogenesis and cancer progression through R-loop-mediated RPL/RPS transcription. Nature Communications. 16(1). 7409–7409. 1 indexed citations

Li, Hongquan, et al.. (2025). The liver-specific long noncoding RNA FAM99B inhibits ribosome biogenesis and cancer progression through cleavage of dead-box Helicase 21. Cell Death and Disease. 16(1). 97–97. 3 indexed citations

Liu, Yizhe, Qili Shi, Yanfang Liu, et al.. (2024). Fibrillarin reprograms glucose metabolism by driving the enhancer-mediated transcription of PFKFB4 in liver cancer. Cancer Letters. 602. 217190–217190. 3 indexed citations

Liu, Yanfang, Qili Shi, Bing Chen, et al.. (2024). Glucose‐induced LINC01419 reprograms the glycolytic pathway by recruiting YBX1 to enhance PDK1 mRNA stability in hepatocellular carcinoma. Clinical and Translational Medicine. 14(12). e70122–e70122. 2 indexed citations

Li, Xinrong, Qili Shi, Wenying Qiu, et al.. (2024). Elevated choline drives KLF5-dominated transcriptional reprogramming to facilitate liver cancer progression. Oncogene. 43(42). 3121–3136. 4 indexed citations

Liu, Yizhe, Qili Shi, Yue Su, Zhiao Chen, & Xianghuo He. (2024). Heat shock transcription factor 1 facilitates liver cancer progression by driving super‐enhancer‐mediated transcription of MYCN. Cancer Medicine. 13(17). e70157–e70157. 3 indexed citations

Chen, Zhiao, Qili Shi, Yiming Zhao, et al.. (2024). Long-read transcriptome landscapes of primary and metastatic liver cancers at transcript resolution. Biomarker Research. 12(1). 4–4. 3 indexed citations

Li, Hongquan, Yanfang Liu, Xinrong Li, et al.. (2023). Aldolase A Accelerates Cancer Progression by Modulating mRNA Translation and Protein Biosynthesis via Noncanonical Mechanisms. Advanced Science. 10(26). e2302425–e2302425. 21 indexed citations

10.

Shi, Qili, et al.. (2023). MicroRNA-148a-3p suppresses the glycolysis and Cell proliferation by targeting transmembrane protein 54 in liver cancer. Biochemical and Biophysical Research Communications. 695. 149424–149424. 1 indexed citations

11.

Shi, Qili, Xinrong Li, Yizhe Liu, Zhiao Chen, & Xianghuo He. (2023). FLIBase: a comprehensive repository of full-length isoforms across human cancers and tissues. Nucleic Acids Research. 52(D1). D124–D133. 6 indexed citations

12.

Ma, Guoming, et al.. (2022). Brain region-specific synaptic function of FUS underlies the FTLD-linked behavioural disinhibition. Brain. 146(5). 2107–2119. 5 indexed citations

13.

Shi, Qili, Jie Ding, Xinrong Li, et al.. (2022). RNA binding protein RALY activates the cholesterol synthesis pathway through an MTA1 splicing switch in hepatocellular carcinoma. Cancer Letters. 538. 215711–215711. 20 indexed citations

14.

Hu, Wei, Yangjun Wu, Qili Shi, et al.. (2022). Systematic characterization of cancer transcriptome at transcript resolution. Nature Communications. 13(1). 6803–6803. 11 indexed citations

15.

Shi, Qili, Yizhe Liu, Qun‐Ying Lei, et al.. (2022). A pathway-guided strategy identifies a metabolic signature for prognosis prediction and precision therapy for hepatocellular carcinoma. Computers in Biology and Medicine. 144. 105376–105376. 10 indexed citations

16.

Shen, Libing, et al.. (2021). Comprehensive Analysis of APA Events and Their Association With Tumor Microenvironment in Lung Adenocarcinoma. Frontiers in Genetics. 12. 645360–645360. 14 indexed citations

17.

Lin, Jie, Qili Shi, Xiaohua Sun, et al.. (2020). Environmental exposure to cooking oil fumes and fatty liver disease. Annals of Palliative Medicine. 9(6). 3810–3817. 10 indexed citations

18.

Shi, Qili, et al.. (2019). Integrative analysis identifies DNMTs against immune-infiltrating neutrophils and dendritic cells in colorectal cancer. Epigenetics. 14(4). 392–404. 15 indexed citations

19.

Shen, Libing, Qili Shi, & Wenyuan Wang. (2018). Double agents: genes with both oncogenic and tumor-suppressor functions. Oncogenesis. 7(3). 25–25. 95 indexed citations

20.

Shi, Qili. (2011). Pathological Analysis of Splenic Littoral Cell Angioma: A Report of 6 Cases. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact